首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1338659篇
  免费   112791篇
  国内免费   6373篇
耳鼻咽喉   16719篇
儿科学   43025篇
妇产科学   36556篇
基础医学   183662篇
口腔科学   36276篇
临床医学   120725篇
内科学   278654篇
皮肤病学   31894篇
神经病学   110594篇
特种医学   55576篇
外国民族医学   274篇
外科学   210371篇
综合类   31537篇
现状与发展   2篇
一般理论   415篇
预防医学   106642篇
眼科学   28090篇
药学   93718篇
  5篇
中国医学   2230篇
肿瘤学   70858篇
  2018年   13386篇
  2017年   10635篇
  2016年   12799篇
  2015年   14298篇
  2014年   19951篇
  2013年   29741篇
  2012年   36246篇
  2011年   38911篇
  2010年   24374篇
  2009年   23907篇
  2008年   36369篇
  2007年   38784篇
  2006年   39914篇
  2005年   38498篇
  2004年   36736篇
  2003年   35830篇
  2002年   33840篇
  2001年   66059篇
  2000年   67924篇
  1999年   56592篇
  1998年   16728篇
  1997年   15020篇
  1996年   16017篇
  1995年   16235篇
  1994年   15098篇
  1993年   14154篇
  1992年   47099篇
  1991年   45749篇
  1990年   43970篇
  1989年   41815篇
  1988年   38760篇
  1987年   38083篇
  1986年   35860篇
  1985年   34636篇
  1984年   26358篇
  1983年   22110篇
  1982年   13847篇
  1981年   12447篇
  1980年   11718篇
  1979年   23544篇
  1978年   17072篇
  1977年   14385篇
  1976年   13182篇
  1975年   13723篇
  1974年   16093篇
  1973年   15396篇
  1972年   14173篇
  1971年   13036篇
  1970年   11881篇
  1969年   11101篇
排序方式: 共有10000条查询结果,搜索用时 10 毫秒
121.
122.
123.
124.
125.
126.

Objectives

Vaccinations are the main pillar of primary prevention for infectious diseases. To guide and prioritize public health interventions, the Regional Health Agency has asked the Prevention, Vaccination, and Screening Center of the Sarthe department to assess vaccination coverage (VC) at the sub-departmental level. The main objective was to measure the VC among school children aged 14–15 years in Sarthe at the sub-departmental level.

Patients and methods

We conducted a VC evaluation survey at the administrative district level among school children aged 14–15 years in the Sarthe department during the first quarter of the 2015–2016 school year.

Results

Among 2384 randomly selected school children, 1171 were included in the study. At the departmental level, 85% of children were up to date for DTP, 72% for pertussis, 45% for hepatitis B, 31% for meningococcus C, 93% for measles, and 18% of girls had received at least one dose of the HPV vaccine. Vaccination coverage varied by administrative districts.

Conclusion

At the departmental level, all VC were below national goals. Territorial disparities could be explained by sociodemographic differences or differences in medical practices. This survey allowed us to identify areas and population groups where the CV rate justified public health actions.  相似文献   
127.

Objective

To assess the incidence of pertussis (whooping cough) in subjects aged 50 years and older in France.

Methods

Participating family physicians (FPs) using the patient record management software AxiSanté® included patients aged 50 years and older, who had signed an informed consent form, presenting with persistent cough for 7 to 21 days. Bordetella genetic material was detected by polymerase chain reaction (PCR) on nasopharyngeal samples collected at the FP's discretion.

Results

A total of 42 FPs included 129 patients from June 2013 to August 2014 (large cities: 38; medium-sized cities: 57; rural areas: 34); 106 samples were analyzed. Overall, 30 pertussis cases were diagnosed: 10 cases confirmed by PCR, 18 purely clinical cases, and two direct epidemiological cases. The crude incidence rate per 100,000 patients aged  50 years was 103.6 (95% CI: 69.9–47.9): 77.1 in large cities, 103.1 in medium-sized cities, and 143.9 in rural areas. The extrapolated incidence rate per 100,000 persons aged  50 years was 187.1 (95% CI: 126.2–67.1): 131.1 in large cities, 256.1 in medium-sized cities, and 242.2 in rural areas.

Conclusion

The population aged 50 years and older can serve as a reservoir. Its role in Bordetella pertussis circulation should be taken into account for pertussis booster vaccination programs.  相似文献   
128.
129.
130.
Introduction: G protein-coupled receptor (GPCR) kinase-2 (GRK2) is a regulator of GPCRs, in particular β-adrenergic receptors (ARs), and as demonstrated by decades of investigation, it has a pivotal role in the development and progression of cardiovascular disease, like heart failure (HF). Indeed elevated levels and activity of this kinase are able to promote the dysfunction of both cardiac and adrenal α- and β-ARs and to dysregulate other protective signaling pathway, such as sphingosine 1-phospate and insulin. Moreover, recent discoveries suggest that GRK2 can signal independently from GPCRs, in a ‘non-canonical’ manner, via interaction with non-GPCR molecule or via its mitochondrial localization.

Areas covered: Based on this premise, GRK2 inhibition or its genetic deletion has been tested in several disparate animal models of cardiovascular disease, showing to protect the heart from adverse remodeling and dysfunction.

Expert opinion: HF is one of the leading cause of death worldwide with enormous health care costs. For this reason, the identification of new therapeutic targets like GRK2 and strategies such as its inhibition represents a new hope in the fight against HF development and progression. Herein, we will update the readers about the ‘state-of-art’ of GRK2 inhibition as a potent therapeutic strategy in HF.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号